TET2 c.1178del ;(p.S393Lfs*34)

Variant ID: 4-106156277-TC-T

NM_001127208.2(TET2):c.1178del;(p.S393Lfs*34)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo.

Blood Cancer Journal
Verger, Emmanuelle E; Soret-Dulphy, Juliette J; Maslah, Nabih N; Roy, Lydia L; Rey, Jerome J; Ghrieb, Zineb Z; Kralovics, Robert R; Gisslinger, Heinz H; Grohmann-Izay, Barbara B; Klade, Christoph C; Chomienne, Christine C; Giraudier, Stéphane S; Cassinat, Bruno B; Kiladjian, Jean-Jacques JJ
Publication Date: 2018-10-04

Variant appearance in text: TET2: S393Lfs*34
PubMed Link: 30287855
Variant Present in the following documents:
  • Main text
  • 41408_2018_Article_133.pdf
View BVdb publication page



Applicability of next-generation sequencing to decalcified formalin-fixed and paraffin-embedded chronic myelomonocytic leukaemia samples.

International Journal Of Clinical And Experimental Pathology
Bernard, Veronica V; Gebauer, Niklas N; Dinh, Thomas T; Stegemann, Judith J; Feller, Alfred C AC; Merz, Hartmut H
Publication Date: 2014

Variant appearance in text: TET2: S393LfsX34
PubMed Link: 24817963
Variant Present in the following documents:
  • Main text
View BVdb publication page